Qube Research & Technologies (QRT)
GTBP icon

Qube Research & Technologies (QRT)’s GT Biopharma GTBP Stock Holding History

Qube Research & Technologies (QRT)’s Portfolio GTBP Stock Details GTBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Hold
0
– -$1 – 4628
2023
Q4 		– Hold
0
– – – 4274
2023
Q3 		– Hold
0
– – – 4182
2022
Q4 		– Sell
-496
Closed -$26K – 2675
2022
Q3 		$26K Sell
496
-12
-2% -$918 ﹤0.01% 2260
2022
Q2 		$46K Buy
+508
New +$38.5K ﹤0.01% 2140
2021
Q4 		– Sell
-477
Closed -$96K – 2696
2021
Q3 		$96K Buy
+477
New +$144K ﹤0.01% 1800

Other funds holding GTBP

Bank of Montreal
Bank of Montreal Toronto, Ontario, Canada $269B AUM 31.4% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

Qube Research & Technologies (QRT)'s GTBP Position: Q1 2024 in Review

Qube Research & Technologies (QRT) held its GT Biopharma (GTBP) position steady in Q1 2024 at 0 shares worth $0. The position accounts for ﹤0.01% of the portfolio, ranked #4628.

Qube Research & Technologies (QRT) first reported a position in GTBP in Q3 2021 and has held it in 3 quarters since. The position peaked at $96K in Q3 2021. 17 funds tracked by Wall St. Rank hold GTBP as of Q1 2024.

  • Qube Research & Technologies (QRT) held 0 shares of GT Biopharma worth $0 as of Q1 2024.
  • Qube Research & Technologies (QRT) left its GT Biopharma share count unchanged in Q1 2024.
  • GT Biopharma made up ﹤0.01% of Qube Research & Technologies (QRT)'s portfolio in Q1 2024, its #4628 holding.
  • Qube Research & Technologies (QRT) first reported a position in GT Biopharma in Q3 2021 and has held it in 3 quarters since.
  • Qube Research & Technologies (QRT)'s GT Biopharma position peaked at $96K in Q3 2021.
  • 17 funds tracked by Wall St. Rank held GT Biopharma as of Q1 2024.

Based on Qube Research & Technologies (QRT)'s 13F filing for Q1 2024, filed 14 May 2024.